Enumeral Biomedical

About:

Enumeral Biomedical uses a nanotechnology-enabled process for therapeutic discovery, immune profiling and personalized medicine.

Website: http://enumeral.com

Top Investors: Bantam Group, 180 Degree Capital, Montrose Capital Partners

Description:

Enumeral Biomedical uses its microengraving (nanotechnology-enabled) process to address opportunities in immunology including therapeutic discovery, immune profiling and personalized medicine.

Total Funding Amount:

$33M

Headquarters Location:

New York, New York, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)enumeral.com

Founders:

Arthur H. Tinkelenberg, John J. Rydzewski

Number of Employees:

11-50

Last Funding Date:

2016-08-03

IPO Status:

Delisted

Industries: